Archives: Speakers

Daniel Martínez studied Biochemistry at the Universidad Autónoma de Madrid and spent two years in basic research in genomics and transcriptomics. On November 2018, he started working as a CRA and, in 2022, he moved to Exeltis for globally managing Clinical Trials. Daniel focuses on implementing AI and innovative technologies throughout clinical trials to shorten timelines, improve data quality, and enhance participant experience. He collaborates with various companies and leads internal projects where AI promises to improve clinical trials.

Agustin Rodriguez is a seasoned business partner at Troutman Pepper Locke with extensive experience in guiding clients through complex regulatory landscapes in industries such as tobacco, cannabis, and gambling. As a partner in the firm’s Regulatory Investigations, Strategy + Enforcement (RISE) Practice Group and its Tobacco + Nicotine and Cannabis law practices, he provides strategic counsel on complex regulatory compliance issues, including licensing, taxation, marketing, and advertising.

Before joining the firm, Agustin served as Vice President and Associate General Counsel at Altria Group, Inc., where he managed compliance, corporate governance, litigation, and transactional matters globally. Fluent in Spanish and proficient in Portuguese, Agustin has developed compliance programs across Europe, Latin America, Asia, and Africa, addressing risks related to antitrust, anticorruption, the FCPA, and corporate social responsibility.

Bryan Haynes is an experienced attorney at Troutman Pepper Locke, specializing in regulatory compliance and enforcement within the tobacco industry. As a key member of the firm’s Regulatory Investigations, Strategy + Enforcement (RISE) Practice Group and head of the Tobacco + Nicotine practice, he adeptly assists clients in navigating complex regulatory landscapes. Bryan’s expertise spans FDA requirements, tobacco taxation, and administrative disputes. He has been instrumental in advising on the Family Smoking Prevention and Tobacco Control Act and the FDA’s deeming rule. A skilled litigator, Bryan has successfully represented clients in state and federal courts, ensuring compliance and mitigating risks aligned with business objectives. His comprehensive knowledge and strategic approach make him an invaluable asset to tobacco manufacturers, distributors, retailers, and suppliers.

Karen Benson has over 20 years of experience in the pharmaceutical industry, serving in various roles including medical affairs and regulatory affairs.

Throughout her career in regulatory affairs, Karen has worked across the various phases of development (PreIND, Phase 1 through Phase 4) and has experience in Oncology, Investigational New Drug Applications (INDs) and IND submissions, clinical trial applications (CTAs) and submissions, New Drug Applications (NDAs) and post market submissions.

Jonathan Kornstein is Vice President, Rare Disease and Pediatrics at Caidya and has over 29 years of experience in the Pharmaceutical and CRO industry. He has demonstrated a depth of project management and clinical operations experience in a multitude of therapeutic areas. Jonathan provides strategic consultation and direction to clinical management, commercial development, and business development teams facilitating overall success in clinical trials.  Jonathan takes a patient centered approach in implementing clinical trials and has a significant amount of experience overseeing rare indications in clinical trials.

Jonathan holds a bachelor’s degree in biology from Hamilton College in Clinton, New York and is homebased in Chapel Hill, North Carolina.

Gemma is a Project Director with over 20 years of clinical research experience, including 14 years in project management roles with a specialist focus on patient education, recruitment and retention. She has a proven record of supporting Caidya’s biopharma clients with timely and high-quality delivery of their studies. She has experience across a number of therapy areas, including expertise in Rare Disease (Lipoprotein Lipase Deficiency, Glioblastoma, Lupus, Familial Hypercholesterolemia, TGCT) and Pediatrics (Vaccination, Pancreatitis, Bacterial Infection)